Quadrant Capital »

Adaptimmune Therapeutics shares owned by Quadrant Capital

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Adaptimmune Therapeutics

Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 202505k10k15k05k10k
Value ($)Share countHistorical ADAP position of Quadrant Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $12k 12k 0.95
2024-06-30 $3.1k 3.2k 0.98
2024-03-31 $9.9k 6.3k 1.58
2022-09-30 $999 1.0k 0.96
2021-12-31 $9.0k 2.5k 3.65
2021-09-30 $17k 3.2k 5.28
2020-06-30 $1.0k 131 7.63